Innovator IBD 50 ETF (NYSEARCA:FFTY) Shares Up 1.2% – Still a Buy?

Shares of Innovator IBD 50 ETF (NYSEARCA:FFTY) were up 1.2% during mid-day trading on Monday. The stock traded as high as $35.94 and last traded at $35.83. Approximately 9,000 shares were traded during trading, a decline of 83% from the average daily volume of 52,622 shares. The stock had previously closed at $35.39.

Innovator IBD 50 ETF Price Performance

The business has a fifty day simple moving average of $36.24 and a two-hundred day simple moving average of $37.92. The company has a market cap of $69.87 million, a PE ratio of 30.34 and a beta of 1.48.

Institutional Investors Weigh In On Innovator IBD 50 ETF

Hedge funds have recently made changes to their positions in the stock. KFG Wealth Management LLC purchased a new position in Innovator IBD 50 ETF in the second quarter valued at about $201,000. Trail Ridge Investment Advisors LLC purchased a new stake in shares of Innovator IBD 50 ETF during the second quarter valued at about $210,000. Royal Bank of Canada lifted its position in shares of Innovator IBD 50 ETF by 3,222.5% during the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after buying an additional 17,724 shares during the last quarter. Guardian Wealth Advisors LLC NC bought a new stake in shares of Innovator IBD 50 ETF in the 2nd quarter valued at about $507,000. Finally, WorthPointe LLC boosted its holdings in shares of Innovator IBD 50 ETF by 18.3% in the 2nd quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock valued at $1,295,000 after buying an additional 3,771 shares in the last quarter.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.